Paige Raises $45M in Series C
Paige has successfully raised $45M in a Series C at a $120M valuation led by Northpond Ventures, Goldman Sachs.
Company Overview
Paige is a HealthTech company headquartered in New York, NY, founded in 2017 with 100+ employees.
AI cancer diagnosis platform
Fundraising Details
- Amount Raised: $45M
- Round Type: Series C
- Valuation: $120M
- Date: 2020-09-22
- Investors: Northpond Ventures, Goldman Sachs
About Paige
AI cancer diagnosis platform The company is positioned in the HealthTech sector, serving a growing market with innovative solutions.
Key Information
- Headquarters: New York, NY
- Founded: 2017
- Team Size: 100+
- Industry: HealthTech
What This Means
This funding round demonstrates strong investor confidence in Paige's vision and execution. The capital will likely be used to:
- Scale Operations: Expand the team and operational capacity
- Product Development: Enhance existing products and develop new features
- Market Expansion: Enter new markets and strengthen presence in existing ones
- Technology Investment: Invest in infrastructure and technology capabilities
Industry Context
The HealthTech sector continues to attract significant investment as companies innovate to meet evolving market demands. Paige's successful fundraising reflects the strong fundamentals and growth potential in this space.
Valuation Milestone
Reaching a $120M valuation marks an important milestone for Paige, positioning the company among notable players in the HealthTech industry.
Looking Ahead
With this new capital, Paige is well-positioned to execute on its growth strategy and continue building innovative solutions in the HealthTech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.
---
This fundraising news was reported on 2020-09-22. For more information about Paige, visit their headquarters at New York, NY.
